169 related articles for article (PubMed ID: 17760597)
1. Botulinum toxin A adjunctive use in manual chemabrasion: controlled long-term study for treatment of upper perioral vertical wrinkles.
Kadunc BV; Trindade DE Almeida AR; Vanti AA; DI Chiacchio N
Dermatol Surg; 2007 Sep; 33(9):1066-72; discussion 1072. PubMed ID: 17760597
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
3. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.
Carruthers J; Carruthers A
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S10-7. PubMed ID: 17241408
[TBL] [Abstract][Full Text] [Related]
6. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
Chajchir I; Modi P; Chajchir A
Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of small and large gel-particle hyaluronic acid in the correction of perioral wrinkles.
Brandt F; Bassichis B; Bassichis M; O'Connell C; Lin X
J Drugs Dermatol; 2011 Sep; 10(9):982-7. PubMed ID: 22052266
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
Hantash BM; Gladstone HB
Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study.
Levy JL; Servant JJ; Jouve E
J Cosmet Laser Ther; 2004 May; 6(1):16-20. PubMed ID: 15370408
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin A in the treatment of wrinkles in the upper third of the face].
Gassia V
Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S299-305. PubMed ID: 19931689
[TBL] [Abstract][Full Text] [Related]
11. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
[TBL] [Abstract][Full Text] [Related]
12. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
13. Eyebrow height after botulinum toxin type A to the glabella.
Carruthers A; Carruthers J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
Blumenfeld AM; Schim JD; Chippendale TJ
Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
[TBL] [Abstract][Full Text] [Related]
15. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
[TBL] [Abstract][Full Text] [Related]
16. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
17. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
Carruthers A; Bogle M; Carruthers JD; Dover JS; Arndt KA; Hsu TS; Poirier J
Dermatol Surg; 2007 May; 33(5):567-71. PubMed ID: 17451579
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A treatment of perioral rhytides.
Semchyshyn N; Sengelmann RD
Dermatol Surg; 2003 May; 29(5):490-5; discussion 495. PubMed ID: 12752516
[TBL] [Abstract][Full Text] [Related]
19. The use of botulinum toxin A in perioral rejuvenation.
Kaplan SE; Sherris DA; Gassner HG; Friedman O
Facial Plast Surg Clin North Am; 2007 Nov; 15(4):415-21, v-vi. PubMed ID: 18005882
[TBL] [Abstract][Full Text] [Related]
20. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids.
de Boulle K
J Cosmet Laser Ther; 2008 Jun; 10(2):87-92. PubMed ID: 18569261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
